000 | 01271 a2200385 4500 | ||
---|---|---|---|
005 | 20250512115228.0 | ||
264 | 0 | _c19750108 | |
008 | 197501s 0 0 eng d | ||
022 | _a0001-7604 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSvestka, J | |
245 | 0 | 0 |
_aA controlled comparison of oxypertine and perphenazine in schizophrenic psychoses. _h[electronic resource] |
260 |
_bActivitas nervosa superior _cAug 1974 |
||
300 |
_a165-6 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aBipolar Disorder _xdrug therapy |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aDrug Evaluation |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIndoles _xadverse effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMovement Disorders _xchemically induced |
650 | 0 | 4 |
_aPerphenazine _xadverse effects |
650 | 0 | 4 |
_aPiperazines _xadverse effects |
650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
650 | 0 | 4 |
_aTranquilizing Agents _xadverse effects |
700 | 1 | _aNáhunek, K | |
700 | 1 | _aRodová, A | |
700 | 1 | _aCesková, E | |
773 | 0 |
_tActivitas nervosa superior _gvol. 16 _gno. 3 _gp. 165-6 |
|
999 |
_c4612614 _d4612614 |